Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Incidence of cancer in patients with chronic heart failure: a long-term follow-up study.

Banke A, Schou M, Videbaek L, Møller JE, Torp-Pedersen C, Gustafsson F, Dahl JS, Køber L, Hildebrandt PR, Gislason GH.

Eur J Heart Fail. 2016 Mar;18(3):260-6. doi: 10.1002/ejhf.472. Epub 2016 Jan 10.

2.

Effect of extended follow-up in a specialized heart failure clinic on adherence to guideline recommended therapy: NorthStar Adherence Study.

Schou M, Gislason G, Videbaek L, Kober L, Tuxen C, Torp-Pedersen C, Hildebrandt PR, Gustafsson F; NorthStar Investigators.

Eur J Heart Fail. 2014 Nov;16(11):1249-55. doi: 10.1002/ejhf.176. Epub 2014 Oct 14.

3.

Incidence and predictors of end-stage renal disease in outpatients with systolic heart failure.

Bosselmann H, Gislason G, Gustafsson F, Hildebrandt PR, Videbaek L, Kober L, Torp-Pedersen C, Tonder N, Rossing K, Christensen S, Kamper AL, Heaf J, Schou M.

Circ Heart Fail. 2013 Nov;6(6):1124-31. doi: 10.1161/CIRCHEARTFAILURE.113.000553. Epub 2013 Oct 18.

PMID:
24141097
4.

Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study).

Schou M, Gustafsson F, Videbaek L, Andersen H, Toft J, Nyvad O, Ryde H, Fog L, Jensen JC, Nielsen OW, Lind-Rasmussen S, Abdulla J, Hildebrandt PR; NorthStar Investigators.

Eur J Heart Fail. 2013 Jul;15(7):818-27. doi: 10.1093/eurjhf/hft037. Epub 2013 Mar 18.

5.

Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar).

Schou M, Gustafsson F, Videbaek L, Tuxen C, Keller N, Handberg J, Sejr Knudsen A, Espersen G, Markenvard J, Egstrup K, Ulriksen H, Hildebrandt PR; NorthStar Investigators, all members of The Danish Heart Failure Clinics Network.

Eur Heart J. 2013 Feb;34(6):432-42. doi: 10.1093/eurheartj/ehs235. Epub 2012 Aug 8.

PMID:
22875412
6.

Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.

Egstrup M, Schou M, Tuxen CD, Kistorp CN, Hildebrandt PR, Gustafsson F, Faber J, Goetze JP, Gustafsson I.

Am J Cardiol. 2012 Aug 15;110(4):552-7. doi: 10.1016/j.amjcard.2012.04.033. Epub 2012 May 10.

PMID:
22579083
7.

Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis.

Egstrup M, Schou M, Gustafsson I, Kistorp CN, Hildebrandt PR, Tuxen CD.

Eur J Heart Fail. 2011 Mar;13(3):319-26. doi: 10.1093/eurjhf/hfq216. Epub 2010 Dec 8.

8.

Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial.

Iversen KK, Teisner B, Winkel P, Gluud C, Kjøller E, Kolmos HJ, Hildebrandt PR, Hilden J, Kastrup J; CLARICOR Trial Group.

Atherosclerosis. 2011 Jan;214(1):203-8. doi: 10.1016/j.atherosclerosis.2010.10.025. Epub 2010 Nov 3.

PMID:
21093861
9.

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.

Eugen-Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, Langkilde A, Petersen J, Pielak T, Møller LN, Jeppesen J, Lyngbaek S, Fenger M, Olsen MH, Hildebrandt PR, Borch-Johnsen K, Jørgensen T, Haugaard SB.

J Intern Med. 2010 Sep;268(3):296-308. doi: 10.1111/j.1365-2796.2010.02252.x. Epub 2010 May 28.

10.

High mortality among heart failure patients treated with antidepressants.

Veien KT, Videbæk L, Schou M, Gustafsson F, Hald-Steffensen F, Hildebrandt PR; Danish Heart Failure Clinics Network.

Int J Cardiol. 2011 Jan 7;146(1):64-7. doi: 10.1016/j.ijcard.2010.01.006. Epub 2010 Feb 26.

PMID:
20188426
11.

Urine albumin/creatinine ratio, high sensitivity C-reactive protein and N-terminal pro brain natriuretic peptide--three new cardiovascular risk markers--do they improve risk prediction and influence treatment?

Olsen MH, Sehestedt T, Lyngbaek S, Hansen TW, Rasmussen S, Wachtell K, Torp-Pedersen C, Hildebrandt PR, Ibsen H.

Curr Vasc Pharmacol. 2010 Jan;8(1):134-9.

PMID:
19485906
12.

Incidence and predictors of hospitalization or death in patients managed in multidisciplinary heart failure clinics.

Gustafsson F, Schou M, Videbaek L, Dridi N, Ryde H, Handberg J, Hildebrandt PR; Danish Heart Failure Clinics Network.

Eur J Heart Fail. 2009 Apr;11(4):413-9. doi: 10.1093/eurjhf/hfp025. Epub 2009 Feb 21.

13.

Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter study.

Schou M, Gustafsson F, Videbaek L, Markenvard J, Ulriksen H, Ryde H, Jensen JC, Nielsen T, Knudsen AS, Tuxen CD, Handberg J, Sørensen PJ, Espersen G, Lind-Rasmussen S, Keller N, Egstrup K, Nielsen OW, Abdulla J, Nyvad O, Toft J, Hildebrandt PR.

Am Heart J. 2008 Oct;156(4):649-55.

PMID:
18946891
14.

New risk markers may change the HeartScore risk classification significantly in one-fifth of the population.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.

J Hum Hypertens. 2009 Feb;23(2):105-12. doi: 10.1038/jhh.2008.112. Epub 2008 Sep 11.

PMID:
18784734
15.

C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.

Jeppesen J, Hansen TW, Olsen MH, Rasmussen S, Ibsen H, Torp-Pedersen C, Hildebrandt PR, Madsbad S.

Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):594-8. doi: 10.1097/HJR.0b013e328308bb8b.

PMID:
18753952
16.

Impact of the metabolic syndrome on the predictive values of new risk markers in the general population.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.

J Hum Hypertens. 2008 Sep;22(9):634-40. doi: 10.1038/jhh.2008.40. Epub 2008 Jun 5.

PMID:
18528412
17.

Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure.

Rosenberg J, Gustafsson F, Remme WJ, Riegger GA, Hildebrandt PR.

Cardiovasc Drugs Ther. 2008 Aug;22(4):305-11. doi: 10.1007/s10557-008-6099-6. Epub 2008 Feb 29.

PMID:
18309461
18.

Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.

J Hypertens. 2008 Jan;26(1):26-34.

PMID:
18090537
19.

Losartan versus atenolol on 24-hour ambulatory blood pressure. A LIFE substudy.

Bang LE, Wiinberg N, Wachtell K, Larsen J, Olsen MH, Tuxen C, Hildebrandt PR, Ibsen H.

Blood Press. 2007;16(6):392-7.

PMID:
18058457
20.

Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.

Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.

Am J Cardiol. 2007 Nov 15;100(10):1571-6.

PMID:
17996522
21.

Effects of body mass index and age on N-terminal pro brain natriuretic peptide are associated with glomerular filtration rate in chronic heart failure patients.

Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.

Clin Chem. 2007 Nov;53(11):1928-35. Epub 2007 Sep 14.

22.

Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarction.

Gustafsson I, Kistorp CN, James MK, Faber JO, Dickstein K, Hildebrandt PR; OPTIMAAL Study Group.

Am Heart J. 2007 Sep;154(3):470-6.

PMID:
17719292
23.

Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice.

Pedersen F, Mehlsen J, Raymond I, Atar D, Skjoldborg US, Hildebrandt PR.

Int J Clin Pract. 2007 Sep;61(9):1481-91.

24.
25.

Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study.

Obel N, Thomsen HF, Kronborg G, Larsen CS, Hildebrandt PR, Sørensen HT, Gerstoft J.

Clin Infect Dis. 2007 Jun 15;44(12):1625-31. Epub 2007 May 10.

PMID:
17516408
26.

A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.

Dargie HJ, Hildebrandt PR, Riegger GA, McMurray JJ, McMorn SO, Roberts JN, Zambanini A, Wilding JP.

J Am Coll Cardiol. 2007 Apr 24;49(16):1696-704. Epub 2007 Apr 6.

27.

N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.

Madsen LH, Ladefoged S, Corell P, Schou M, Hildebrandt PR, Atar D.

Kidney Int. 2007 Mar;71(6):548-54. Epub 2007 Feb 14.

28.

N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.

Eur Heart J. 2007 Jun;28(11):1374-81. Epub 2007 Jan 22.

PMID:
17242007
29.

Long-term clinical variation of NT-proBNP in stable chronic heart failure patients.

Schou M, Gustafsson F, Kjaer A, Hildebrandt PR.

Eur Heart J. 2007 Jan;28(2):177-82. Epub 2007 Jan 11.

PMID:
17218450
30.

N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.

Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR.

J Hypertens. 2006 Aug;24(8):1531-9.

PMID:
16877955
31.

Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state.

Schou M, Gustafsson F, Nielsen PH, Madsen LH, Kjaer A, Hildebrandt PR.

Eur J Heart Fail. 2007 Jan;9(1):68-74. Epub 2006 Jul 7.

32.

[Prognostic value of N-terminal pro-BNP-type natriuretic peptide in patients with stable coronary heart disease--secondary publication].

Kragelund CB, Grønning BA, Køber L, Hildebrandt PR, Steffensen R.

Ugeskr Laeger. 2006 Feb 13;168(7):697-700. Danish.

PMID:
16494811
33.

[Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].

Gustafsson I, Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt PR, MacLeod K, Laakso M, Torp-Pedersen CT, Waldenström A; DIGAMI-2 investigatorerne.

Ugeskr Laeger. 2006 Feb 6;168(6):581-4. Danish.

PMID:
16476220
34.

Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature.

Rosenberg J, Gustafsson F, Galatius S, Hildebrandt PR.

Cardiovasc Drugs Ther. 2005 Aug;19(4):301-6.

PMID:
16189620
35.

Kidneys extract BNP and NT-proBNP in healthy young men.

Schou M, Dalsgaard MK, Clemmesen O, Dawson EA, Yoshiga CC, Nielsen HB, Gustafsson F, Hildebrandt PR, Secher NH.

J Appl Physiol (1985). 2005 Nov;99(5):1676-80. Epub 2005 Jul 21.

36.

Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.

Olsen MH, Wachtell K, Tuxen C, Fossum E, Bang LE, Hall C, Ibsen H, Rokkedal J, Devereux RB, Hildebrandt PR.

J Hypertens. 2005 May;23(5):1083-90.

PMID:
15834296
37.

Prevalence of diastolic dysfunction as a possible cause of dyspnea in the elderly.

Pedersen F, Raymond I, Mehlsen J, Atar D, Hildebrandt PR.

Am J Med. 2005 Jan;118(1):25-31.

PMID:
15639206
38.

[Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases].

Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D.

Ugeskr Laeger. 2004 Sep 6;166(37):3201-3. Danish. No abstract available.

PMID:
15384373
39.

Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.

Galatius S, Gustafsson F, Atar D, Hildebrandt PR.

Cardiology. 2004;102(3):160-5. Epub 2004 Aug 27.

PMID:
15334027
40.

How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?

Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D.

J Card Fail. 2004 Aug;10(4):297-303.

PMID:
15309695
41.
42.

24-h Ambulatory blood pressure in patients with ECG-determined left ventricular hypertrophy: left ventricular geometry and urinary albumin excretion-a LIFE substudy.

Wiinberg N, Bang LE, Wachtell K, Larsen J, Olsen MH, Tuxen C, Hildebrandt PR, Rokkedal J, Ibsen H, Devereux RB.

J Hum Hypertens. 2004 Jun;18(6):391-6.

PMID:
15057254
44.

[Natriuretic cardiac hormones. Clinical use in heart failure].

Nielsen SJ, Gøtze JP, Raymond IE, Grønning BA, Kirk V, Bay-Nielsen M, Hildebrandt PR, Aldershvile J.

Ugeskr Laeger. 2004 Jan 19;166(4):248-53. Review. Danish. No abstract available.

PMID:
14964102
45.

Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study.

Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D.

BMJ. 2003 Nov 15;327(7424):1141-2. No abstract available.

46.

The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Pedersen F.

Heart. 2003 Jul;89(7):745-51.

47.

[Clopidogrel: background information and use in clinical practice].

Ziegler BK, Rasmussen LH, Kristensen SD, Hildebrandt PR, Nielsen HK, Husted SE.

Ugeskr Laeger. 2003 Apr 28;165(18):1859-63. Review. Danish.

PMID:
12772393
48.

[Establishment of a nurse-led heart failure clinic. Design and baseline data from the first two years].

Galatius S, Gustafsson F, Kistorp CM, Nielsen PH, Atar D, Hildebrandt PR.

Ugeskr Laeger. 2003 Feb 10;165(7):686-90. Danish.

PMID:
12617047
49.

[Ambulatory 24-hour blood pressure monitoring in a case of liquorice-induced hypertension].

Gustafsson F, Hanash JA, Hildebrandt PR.

Ugeskr Laeger. 2002 Oct 14;164(42):4918-9. Danish.

PMID:
12416071
50.

Neurohumoral prediction of left-ventricular morphologic response to beta-blockade with metoprolol in chronic left-ventricular systolic heart failure.

Groenning BA, Nilsson JC, Hildebrandt PR, Kjaer A, Fritz-Hansen T, Larsson HB, Sondergaard L.

Eur J Heart Fail. 2002 Oct;4(5):635-46.

Supplemental Content

Loading ...
Support Center